Skip to content

5-MeO-DMT: all studies

Page 56 of 110: studies 551 to 560 of 1,097, newest first. Back to the 5-MeO-DMT overview

Research

Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience.

Communications Biology April 18, 2025 S Parker Singleton, Christopher Timmermann, Andrea I. Luppi et al. 17 citations

Psychedelics offer a profound window into the human brain through their robust effects on perception, subjective experience, and brain activity patterns. The serotonergic psychedelic N,N-dimethyltryptamine (DMT) induces a profoundly immersive altered state of consciousness lasting under 20 min, allowing the entire experience to be captured during a single functional magnetic resonance imaging...

Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self

Imaging Neuroscience April 16, 2025 Lorenzo Pasquini, Alexander J. Simon, Courtney L. Gallen et al. 4 citations

Abstract N,N-Dimethyltryptamine (DMT) is a serotonergic psychedelic, known to rapidly induce short-lasting alterations in conscious experience, characterized by a profound and immersive sense of physical transcendence alongside rich and vivid auditory distortions and visual imagery. Multimodal neuroimaging data paired with dynamic analysis techniques offer a valuable approach for identifying...

Functional and structural characterization of the human indolethylamine N-methyltransferase through fluorometric, thermal and computational docking analyses.

Biology direct April 10, 2025 Matteo Ardini, Francesco Angelucci, Francesca Rea et al.

The "psychedelic renaissance" is sparking growing interest in clinical research, along with a rise in clinical trials. Substances such as 3,4-methylenedioxymethamphetamine (MDMA), psilocybin and N,N-dimethyltryptamine (DMT) are involved. The focus of this paper is on indolethylamine N-methyltransferase (INMT), a crucial enzyme in the biosynthesis of key compounds, including DMT, which meets...

Behavioral effects of three synthetic tryptamine derivatives in rodents.

Journal of Psychopharmacology April 4, 2025 Rebecca D. Hill, Ritu A. Shetty, Nathalie Sumien et al.

New synthetic tryptamine derivatives have emerged in the underground market. They act on serotonin receptors mimicking the effects of hallucinogenic drugs such as DOM. The DEA has identified three tryptamine derivatives of concern, 5-MeO-DBT, 5-Cl-DMT, and 4-OH-MiPT. Swiss Webster mice were tested for locomotor activity. Discriminative stimulus effects were tested in male Sprague-Dawley rats...

DOI: 10.1177/02698811251330737 (opens in new tab) Full text (opens in new tab) Serotonin Drug discrimination Hallucinogens psychedelics Entheogens +4

Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study.

Journal of Psychopharmacology April 1, 2025 Manoj K. Doss, Lilian Kloft, Natasha L. Mason et al. 5 citations

Ayahuasca is an Amazonian brew with 5-HT2A-dependent psychedelic effects taken by religious groups globally. Recently, psychedelics have been shown to impair the formation of recollections (hippocampal-dependent episodic memory for specific details) and potentially distort memory while remembering. However, psychedelics spare or enhance the formation of familiarity-based memory...

Utilizing Psychedelics to Enhance Well-Being: A Systematic Review

Journal of Psychoactive Drugs March 31, 2025 Samuel Thomson, Nikos Thomacos 11 citations

Psychedelic-assisted therapy is gaining recognition for its potential to enhance human functioning. While most research has focused on psychedelic' therapeutic use for mental illness, this review applies the PERMA Theory of Well-Being to systematically examine their role in enhancing well-being in healthy individuals. The final search of five academic databases was conducted on February 4,...

Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action

Biological Psychiatry March 8, 2025 Jonathan Repple, Maximilian Bayas, Chiara Möser et al. 8 citations

After decades of limited progress in depression treatment, recent advancements have sparked renewed interest in developing novel antidepressants, particularly rapid-acting antidepressants (RAADs). Despite these promising developments, there remains a significant gap in research on bipolar depression. While several antipsychotics have been investigated for their efficacy in bipolar depression...

DOI: 10.1016/j.biopsych.2025.02.903 (opens in new tab) Mdd #bipolardisorder manic depression Bipolar affective disorder #ketamine ketamine therapy +5

Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample

February 28, 2025 Dan Petrovitch, Samuel Hosford, Andrew K. Littlefield et al. preprint

Psychedelic-assisted therapy (PAT) is an emerging treatment approach that often combines pharmacotherapeutic dosing sessions with more traditional psychotherapy. Despite limited formal regulatory approval, treatment seekers can currently access PAT through a variety of avenues, including ketamine treatment centers and “supported adult use” psilocybin centers in the U.S., drug tourism,...

DOI: 10.31234/osf.io/26tz7_v1 (opens in new tab) Sample material Latent class model Cross-sectional study Nonprobability sampling +4

Hemp proteins conjugated with green tea polyphenol extract form de novo plant-sourced emulsifiers suitable for nanodelivery systems bearing lipophilic psychopharmaceuticals

ChemRxiv February 27, 2025 William Charles Hosie, Mary Augustina Egbuta, Kasra Razmkhah et al. preprint

Nanoformulation is often used to improve the solubility and uptake of bioactives; however, it also protects sensitive bioactives from chemical decomposition. We report a class of biocompatible emulsifiers created by conjugating hemp protein with green tea polyphenols. A simple pH-assisted coupling protocol was employed to synthesize covalent and non-covalent conjugates, which were then used to...

DOI: 10.26434/chemrxiv-2025-pjfn9 (opens in new tab) Full text (opens in new tab) Polyphenol Green tea Conjugated system Traditional medicine

Psychosis in a Military Veteran in the Context of Hallucinogen Use: A Case Report.

Cureus February 19, 2025 Paria Parhami, Sydney E Moriarty, Jay Parikh et al.

N, N-dimethyltryptamine (DMT) is a potent hallucinogenic compound with increasing recreational use despite limited safety data. While DMT use has been linked to psychosis, delusional parasitosis as a specific manifestation remains unreported. We present a novel case of a 60-year-old female veteran with chronic post-traumatic stress disorder (PTSD), a history of major depressive disorder, past...

DOI: 10.7759/cureus.79308 (opens in new tab) Full text (opens in new tab) Substance-induced psychosis Drug-induced psychosis Hallucinogen-induced psychosis Substance-related psychosis +21